| Autor: |
Burns, Daniel K., Chiang, Carl, Welsh-Bohmer, Kathleen A., Brannan, Stephen K., Culp, Meredith, O'Neil, Janet, Runyan, Grant, Harrigan, Patrick, Plassman, Brenda L., Lutz, Michael, Lai, Eric, Haneline, Stephen, Yarnall, David, Yarbrough, Deborah, Metz, Craig, Ponduru, Sridevi, Sundseth, Scott, Saunders, Ann M., Dubois, Bruno, Cummings, Jeffrey, Doody, Rachelle, Lyketsos, Constantine, Reiman, Eric, Welsh-Bohmer, Kathleen A., Welsh-Bohmer, Kathleen A., Sano, Mary, Schneider, Lon, Craft, Suzanne, Espeland, Mark, Monsch, Andreas |
| Zdroj: |
Alzheimer's & Dementia: Translational Research & Clinical Interventions; January 2019, Vol. 5 Issue: 1 p661-670, 10p |
| Abstrakt: |
Alzheimer's disease (AD) is a continuum with neuropathologies manifesting years before clinical symptoms; thus, AD research is attempting to identify more disease-modifying approaches to test treatments administered before full disease expression. Designing such trials in cognitively normal elderly individuals poses unique challenges. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Plný text